The tumor suppressive role of gelsolin is mostly linked to its downregulation in several cancers including breast [37], colon [38], stomach [39], bladder [40], prostate [41], lung [42] as well as in transformed human fibroblast and epithelial cells [43]. This evidence concerns the gene GSN and neoplasm.